Rituximab versus a watch-and-wait approach in patients with advanced-stage, asymptomatic, non-bulky follicular lymphoma: an open-label randomised phase 3 trial-Reference-Cited by-同舟云学术

Rituximab versus a watch-and-wait approach in patients with advanced-stage, asymptomatic, non-bulky follicular lymphoma: an open-label randomised phase 3 trial

Published:2014-04 Issue:4 Volume:15 Page:424-435
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Ardeshna Kirit M,Qian Wendi,Smith Paul,Braganca Nivette,Lowry Lisa,Patrick Pip,Warden June,Stevens Lindsey,Pocock Christopher F E,Miall Fiona,Cunningham David,Davies John,Jack Andrew,Stephens Richard,Walewski Jan,Ferhanoglu Burhan,Bradstock Ken,Linch David C

Publisher

Elsevier BV

Subject

Oncology

Reference18 articles.

1. No initial therapy for stage III and IV non-Hodgkin's lymphomas of favorable histologic types;Portlock;Ann Intern Med,1979

2. The natural history of initially untreated low-grade non-Hodgkin's lymphomas;Horning;N Engl J Med,1984

3. Long-term effect of a watch and wait policy versus immediate systemic treatment for asymptomatic advanced-stage non-Hodgkin lymphoma: a randomised controlled trial;Ardeshna;Lancet,2003

4. Comparison in low-tumor-burden follicular lymphomas between an initial no-treatment policy, prednimustine, or interferon alfa: a randomized study from the Groupe d'Etude des Lymphomes Folliculaires. Groupe d'Etude des Lymphomes de l'Adulte;Brice;J Clin Oncol,1997

5. The treatment of indolent lymphomas: watchful waiting v aggressive combined modality treatment;Young;Semin Hematol,1988

Cited by 317 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical characteristics and outcomes of Brazilian patients with duodenal-type follicular lymphoma: a multicenter retrospective study;Leukemia & Lymphoma;2024-09-10

2. Baseline 18F-FDG PET/CT may contribute to the determination of initial treatment strategy for newly diagnosed follicular lymphoma;European Journal of Radiology;2024-09

3. Impact of positive CD4 cells on event‐free survival in follicular lymphoma patients;Cancer Medicine;2024-09

4. Current and future therapies for follicular lymphoma;Experimental Hematology & Oncology;2024-08-22

5. Risk of transformation by frontline management in follicular and marginal zone lymphomas: a US population–based analysis;Blood Advances;2024-08-16